Related Experiment Video
Updated: Dec 24, 2025

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Does the method of administering fluids matter for contrast-induced nephropathy? REMEDIAL III compares LVEDP versus
Cindy L Grines1, J Jeffrey Marshall1
1Northside Cardiovascular Institute, Atlanta, Georgia, USA.
Insights
Contrast-induced nephropathy (CIN) is a significant risk for patients undergoing angiography. The REMEDIAL III trial investigates optimal hydration strategies to prevent CIN, comparing two targeted regimens in high-risk patients.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) is a serious complication following angiographic procedures, contributing to patient morbidity and mortality.
- Current preventative strategies, including limiting contrast media and intravenous hydration, have limitations due to poorly understood optimal protocols.
Discussion:
- The REMEDIAL III trial aims to optimize hydration protocols for CIN prevention.
- This study will compare two distinct hydration regimens: one guided by continuous urine output monitoring and another by initial left ventricular end-diastolic pressure (LVEDP).
Key Insights:
- Optimal hydration timing, dose, and duration remain critical unanswered questions in CIN prevention.
- Targeted hydration strategies may offer a more effective approach to reducing CIN incidence.
Outlook:
- The trial will randomize 700 high-risk patients to evaluate the efficacy of the two hydration regimens.
- Findings from REMEDIAL III are expected to refine clinical guidelines for CIN prevention in patients undergoing angiography.
Abstract:
Contrast-induced nephropathy (CIN) is a major cause of morbidity and mortality among patients undergoing angiographic procedures. Limiting contrast dose and administration of intravenous normal saline appear to be the best approaches to reducing CIN, but the timing, dose, and duration of optimal hydration is poorly understood. The REMEDIAL III trial protocol outlines two different targeted hydration regimens (guided either by continuous measurement of urine output or by initial left ventricular end diastolic pressure (LVEDP), and 700 patients at high risk of CIN will be randomized.
Related Concept Videos
Hemodialysis III: Nursing Management
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury VI: Nursing Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Acute Kidney Injury V: Interprofessional Care

